Physician profile
Basel Edris
NPI 1629381116
$44,904.36
in general payments reported to CMS, 2019-2025
29 companies · $3,986 in 2025
The $3,986 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,896 · 2020: $2,055 · 2021: $3,532 · 2022: $10K · 2023: $9,627 · 2024: $9,612 · 2025: $3,986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Food and Beverage: $6,884 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,018.62 |
| Food and Beverage | $6,883.53 |
| Education | $323.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21,221.08 | 2019-2025 | Ensite, Ensite Precision, Aveir |
| Biotronik INC. | $6,078.58 | 2019-2023 | Solia, Acticor 7 Vr-T Dx, Edora 8 Dr-T |
| Medtronic, INC. | $4,035.98 | 2021-2025 | Micra, Cardioblate, Affera Mapping System |
| Medtronic Vascular, INC. | $3,740.84 | 2019-2020 | |
| Boston Scientific Corporation | $3,384.90 | 2019-2025 | Watchman Access System, Rhythmia Mapping System, Sq-Rx Pulse Generator |
| Medical Device Business Services, INC. | $3,364.93 | 2021-2024 | Carto 3 |
| Biosense Webster, INC. | $657.57 | 2022-2025 | Carto 3 |
| Baylis Medical Company INC | $614.94 | 2021 | |
| Philips North America LLC | $557.61 | 2022-2025 | (9520) Igt Devices Undivided, Bridge, (9278) Bridge |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $269.17 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $166.73 | 2019 | |
| Amgen INC. | $124.26 | 2019-2023 | Repatha |
| Kestra Medical Technology Services, INC. | $90.98 | 2022-2025 | Assure Wcd |
| Pfizer INC. | $82.27 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $63.60 | 2022-2025 | Verquvo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $50.90 | 2020 | |
| Inspire Medical Systems, INC. | $50.15 | 2025 | Inspire |
| Abiomed | $49.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $47.76 | 2024 | |
| Novo Nordisk INC | $44.58 | 2024-2025 | Ozempic, Wegovy |
| Cardiva Medical, INC. | $43.96 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $27.09 | 2019 | |
| Atricure, INC. | $24.57 | 2024 | |
| Acist Medical Systems, INC. | $24.00 | 2022 | |
| Cvrx, INC. | $23.13 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.80 | 2022 | |
| United Therapeutics Corporation | $16.34 | 2025 | Tyvaso |
| Regeneron Healthcare Solutions, INC. | $16.00 | 2025 | Libtayo |
| Zoll Circulation INC | $14.65 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basel Edris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.